Bowhead Specialty Holdings Inc. (BOW)
Valuation Overview•Is Bowhead Specialty Holdings Inc. Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
High-quality fundamentals with a strong composite quality score of 75/100, backed by robust profitability and solvency.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Solid fundamental quality, though profitability presents a headwind.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
BOW demonstrates strong business quality with robust profitability and healthy margins (highlighted by a massive 20.5% ROIC). This is backed by a fortress balance sheet, holding significant net cash ($234M) and minimal debt risk.
The company is driving exceptional top-line expansion (43.3% 3Y CAGR) paired with highly explosive earnings growth (64.1% EPS 3Y CAGR). Operating efficiency remains adequate with margins around 12.6%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $154.8M | +29.6% | +43.3% | — | — | |
| EBITDA | $20.6M | — | +65.0% | — | — | |
| Net Income | $16.0M | +40.6% | +68.4% | — | — | |
| EPS (Diluted) | $0.48 | +23.3% | +64.1% | — | — | |
| Free Cash Flow | $64.2M | +12.0% | +22.4% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 34.4% | 33.4% | 33.1% | 33.1% |
| Operating Margin | 12.6% | 11.8% | 10.8% | 10.8% |
| Net Margin | 10.0% | 9.2% | 8.4% | 8.4% |
| FCF Margin | 58.6% | 69.8% | 76.1% | 76.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.42 | $0.48 | +14.3% | ||
| Q1'26 | $0.45 | $0.47 | +4.4% | ||
| Q4'25 | $0.40 | $0.47 | +17.5% | ||
| Q3'25 | $0.36 | $0.37 | +2.8% | ||
| Q2'25 | $0.33 | $0.34 | +3.0% | ||
| Q1'25 | $0.35 | $0.42 | +20.0% | ||
| Q4'24 | $0.37 | $0.38 | +2.7% | ||
| Q3'24 | $0.27 | $0.28 | +3.7% |
Total return is -22.0% (1Y), lagging the benchmark by -42.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +6.0% | -1.4% | — |
| 1Y | -22.0% | -42.9% | — |
| 3YCAGR | +6.9% | -13.5% | — |
| 5YCAGR | +4.1% | -8.0% | — |
| 10YCAGR | +2.0% | -12.0% | — |
The S&P 500 is at 31.0x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Bowhead Specialty Holdings Inc. (BOW) valuation, health, and returns.
Based on peer relative multiples, Bowhead Specialty Holdings Inc. appears Slightly expensive versus peers compared to industry peers.
Bowhead Specialty Holdings Inc. has multiple valuation anchors: Peer Relative Fair Value: $25.04 | Wall Street Analyst Target: $27.50 (implying -8.4% upside). A convergence of these signals offers higher conviction.
Bowhead Specialty Holdings Inc. displays good financial health with a composite quality score of 75/100, supported by a Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of 20.5%.
Bowhead Specialty Holdings Inc. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Bowhead Specialty Holdings Inc.'s current growth trajectory is Decelerating. The company achieved +29.6% 1Y revenue growth and +23.3% 1Y EPS growth, compared to its 3Y revenue CAGR of +43.3%.
Wall Street consensus is Buy based on 7 analysts, beating EPS expectations in 100% of recent quarters with a 8-quarter streak. The consensus price target represents a -8.4% change from current levels.
Investment risks for Bowhead Specialty Holdings Inc. include: -42.9% 1-year max drawdown. Volatility risk is characterized by a beta of 0.14x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.